Acrobiosystems for English
icon_bulk_orderConsulta masiva/Pedido rápido
user
  1. Cuadro de mandos
  2. Mi perfil
  3. Mi dirección
  4. Mis pedidos
  5. Afiliación a Acro
Iniciar sesión Registro
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
No hay productos en el carro de la compra
Mi carro|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > Osteoactivin

Osteoactivin

Brief Information

Name:Transmembrane glycoprotein NMB
Target Synonym:Transmembrane Glycoprotein,HGFIN,Transmembrane glycoprotein NMB,Hematopoietic growth factor inducible neurokinin-1 type,GPNMB,Glycoprotein Nmb,Hematopoietic Growth Factor Inducible Neurokinin-1,Glycoprotein Nonmetastatic Melanoma Protein B,Transmembrane Glycoprotein HGFIN,Glycoprotein (Transmembrane) Nmb,Glycoprotein Nmb-Like Protein,Osteoactivin,PLCA3,NMB,UNQ1725/PRO9925
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Product> Filter Results
Por estado del producto :
Por categoría de producto :
Por especies :
Por etiqueta :
Por Conjugado::
Cat. No. Especies Descripción del producto Estructura Pureza Característica
GPB-H5229 Human Human Osteoactivin / GPNMB Protein, His Tag
GPB-H5229-structure
GPB-H5229-sds
ACRO Quality

Synonym Name

GPNMB,HGFIN,NMB,Osteoactivin

Background

Transmembrane glycoprotein NMB (GPNMB) is also known as Transmembrane glycoprotein HGFIN, DC-HIL and Osteoactivin (OA), which belongs to the PMEL/NMB family. GPNMB contains one PKD domain. GPNMB is a transmembrane glycoprotein that is up-regulated in various cancer cells, including in glioblastoma multiforme and is expressed in many melanoma cells, as well as in tissue macrophages. GPNMB protein acts as a downstream mediator of BMP-2 effects on osteoblast differentiation and function. GPNMB participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Glembatumumab vedotin CR-011; CDX-011; CR-011-ADC; CR011-vcMMAE Phase 2 Clinical Celldex Therapeutics Solid tumours; Triple Negative Breast Neoplasms; Osteosarcoma; Breast Neoplasms; Carcinoma, Squamous Cell; Melanoma Details
Glembatumumab vedotin CR-011; CDX-011; CR-011-ADC; CR011-vcMMAE Phase 2 Clinical Celldex Therapeutics Solid tumours; Triple Negative Breast Neoplasms; Osteosarcoma; Breast Neoplasms; Carcinoma, Squamous Cell; Melanoma Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
Correo electrónico
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Dejar un mensaje

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap